4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Follow Us : Follow On Facebook Follow On Twitter Follow On Youtube
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
ACUTE MYELOID LEUKEMIA
Acute Myeloid Leukemia
Dr Ira Shah
M.D, DCH(Gold Medalist), FCPS, DNB
Edited by Dr. Bharat R Agarwal
Consultant Pediatric Hematologist and Oncologist.


Q. What is acute myeloid leukemia?

A. Cancer of the non-lymphoid series of the blood is called myeloid leukemia. It is also called acute myelogenous leukemia or AML, acute nonlymphocytic leukemia or ANLL. It accounts for almost 15- 20% of all childhood leukemia. The ratio of ALL: AML is 4:1.

Q. How does it occur?

A. Though the etiology is still unknown, it is associated with various environmental and genetic factors. It has been seen increasingly in patients with:
  • Genetic disorders :
    However, majority of children with Down's syndrome and AML can be cured of their leukemia. Neonates with Down's syndrome may manifest a transient myeloproliferative syndrome which mimics congenital AML but improves spontaneously with 4-6 weeks.

  • Environmental factors :
    • Exposure to ionizing radiation.
    • Chemical exposure to benzene & hydrocarbons.
    • Treatment with alkylating agents.

Patients with acquired diseases such as myelodysplastic syndromes, myeloproliferative disorders and other pre-leukemic states are at an increased risk.

Q. What are the clinical features?

A. These children present either with very few symptoms or with severe sepsis, bleeding etc, which indicate marrow failure and involvement of extramedullary organs. Certain features are unique to a particular sub-type of AML for e.g.
  • Patients with acute promyelocytic (M3) leukemia may have intravascular coagulopathy due to clotting factor deficiency resulting in severe bleeding.
  • Patients with M4 & M5 AML(monocytic component) may have associated gingival hypertrophy from leukemic infiltration, They may also develop meningeal leukemia, retinal infiltration, leukemia cutis or other localized leukemia infiltrations. They may also have chloromas, which are granulocytic sarcomas seen commonly in the skin and have a dull green color due to the high peroxidase content in the leukemia cell.
In addition, in patients with AML, 1/3 of patients may spleenomegaly. Hyper-uricemia is also very common.

Pediatric Oncology Expertise Views
Pediatric Oncology :Expertise Views
Pediatric Oncology Expertise Views
Pediatric Oncology Expertise Views
 
 
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us